Active

XpressBioX

Switched

BE0770527814

Rechtspersoon Private limited company 1 establishment

Avenue du Parc Industriel 89, 4041 Herstal Vervaardiging van farmaceutische grondstoffen

Active for

5 year, 2 months

Financials

Financial year 2025

Revenue

€ 198,000

Profit

Growing

€ 74,621

▲ 247% vs 2024

Debts

Low

€ 14,924

▼ 82% vs 2024

XpressBioX from Herstal, company number BE0770527814, closed financial year 2025 with a result of € 74,621 after tax. For that financial year XpressBioX recorded revenue of € 198,000 and equity of € 8.9 million. Compared with financial year 2024, the result moved from € -50,833 to € 74,621. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 13, 2026.

What happened at XpressBioX?

What happened at XpressBioX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Cédric VOLANTI stepped down as director. NBB
  • Franck BACKERS stepped down as director. NBB
  • New annual accounts for financial year 2025: profit of € 74,621. Source: NBB ↗
  • Cédric VOLANTI became a director. NBB
  • Jonas Skjødt MOLLER stepped down as director. NBB
  • Jonas Skjødt MOLLER became a director. NBB
  • Franck BACKERS became a director. NBB
  • New establishment in Herstal. KBO

In short

From € 97,001 loss in 2021 to € 74,621 profit in 2025.

Best year ever: 2025, with € 74,621 profit.

Pays suppliers within 147 days on average.

A new publication or filing at XpressBioX? We notify you, reason included.

Follow XpressBioX

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

The shares are held by Sartorius Polyplus SAS (100%). It owns 100% of Sartorius Xpress Biologics SA itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Cédric VOLANTI

Director

Also active at: Sartorius Accessia Pharma, SARTORIUS STEDIM BELGIUM

since 2025 · until 2031

Jonas Skjødt MOLLER

Director

Also active at: Sartorius Xpress Biologics, ACCESSIA PHARMA

since 2024 · until 2025

Franck BACKERS

Managing director

Also active at: Sartorius Xpress Biologics, ACCESSIA PHARMA

since 2024 · until 2030

Shareholders

Participations

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue du Parc Industriel 89

4041 Herstal

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

Details

Company number
0770.527.814
VAT number
BE 0770.527.814
Registered office
Avenue du Parc Industriel 89, 4041 Herstal
Names & denominations
XpressBioX
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
30 June 2021
Peppol
Active · Active since 25 Jun 2026
Activities · NACE

Vervaardiging van farmaceutische grondstoffen

Speur- en ontwikkelingswerk op biotechnologisch gebied

Frequently asked questions

What is the enterprise number of XpressBioX?
The enterprise number of XpressBioX is BE0770527814.
What is the address of XpressBioX?
The registered office of XpressBioX is located at Avenue du Parc Industriel 89, 4041 Herstal.
When was XpressBioX founded?
XpressBioX was founded on 30 June 2021.
What is the main activity of XpressBioX?
The main activity of XpressBioX is "Vervaardiging van farmaceutische grondstoffen" (NACE code 21100).
Does XpressBioX have a website?
No website is currently known for XpressBioX.
How much profit did XpressBioX make in 2025?
XpressBioX posted a profit after taxes of € 74,621 in financial year 2025.
What is the revenue of XpressBioX?
In its most recent annual accounts (2025), XpressBioX reported revenue of € 198,000.
Where can I find the annual accounts of XpressBioX?
XpressBioX files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of XpressBioX?
According to the 2025 annual accounts, the directors of XpressBioX are: Cédric VOLANTI, Jonas Skjødt MOLLER, Franck BACKERS.
Who owns XpressBioX?
The shares are held by Sartorius Polyplus SAS (100%). It owns 100% of Sartorius Xpress Biologics SA itself.
Who are the shareholders of XpressBioX?
According to the 2025 annual accounts, the shareholders of XpressBioX are: Sartorius Polyplus SAS (100%).